You are viewing all content tagged Sleeping Sickness.
You can also read an overview of MSF's work with
Field News | August 27, 2013
MSF has completed a five-month screening project to combat sleeping sickness in DRC's Orientale Province.
Field News | May 24, 2013
MSF's mobile sleeping sickness teams travel to extremely remote areas to treat sleeping sickness.
Voice from the Field | May 13, 2013
MSF medical doctor Papy Banza describes his experience working with the Mobile HAT Team over nine months in South Sudan.
Voice from the Field | May 13, 2013
Olivier was bitten by tsetse flies carrying the sleeping sickness parasite while working deeping in the rainforest in DRC. He received treatment from the MSF team in Bili.
Special Report | October 26, 2012
"Fighting Neglect" charts MSF's 25 years of experience in diagnosing and treating Chagas disease, sleeping sickness, and kala azar in Latin America, Sub-Saharan Africa, South Asia, and the Caucasus.
Field News | August 17, 2012
A mobile team of MSF medics is traveling to remote villages in the unstable southeast of Central African Republic to find and treat people suffering from a neglected disease.
Field News | February 21, 2012
MSF has handed over the management of a hospital in Maitikoulou, Central African Republic, to the Ministry of Health
Op-Eds & Articles | January 31, 2012
In this op-ed Dr. Unni Karunakara, international president of MSF, calls for increased commitment to the elimination of neglected diseases.
Field News | November 17, 2011
Decades of conflict and a lack of government investment have made it difficult for people in DRC to access even the most basic health care.
Research Article | May 26, 2011
Op-Eds & Articles | April 26, 2010
By Dr. Unni Karunakara, incoming president of MSF's International Council, and Dr. Bernard Pecoul, executive director of the Drugs for Neglected Diseases initiative
Ideas & Opinions | February 23, 2010
Over 1 billion people are infected with one of the 14 diseases defined by the World Health Organization (WHO) as neglected tropical diseases
(NTDs). These are the most common infections in the 2.7 billion people living on less than $2 a day and affects those often marginalized and
forgotten by governments, left to suffer in silence. NTDs are diverse but all cause severe disability or death, and bring a major economic burden
on endemic countries.
Transcript | February 22, 2010
Special Report | February 22, 2010
Over one billion people are infected with one or more of the 14 diseases defined by the World Health Organization (WHO) as neglected tropical diseases (NTDs).
Research Article | February 1, 2010
Top Ten Humantarian Crises | December 31, 2009
More than 400 million people are at risk for the neglected tropical diseases (NTDs) visceral leishmaniasis (kala azar), sleeping sickness, Chagas disease, and Buruli ulcer.
Voice from the Field | November 19, 2009
With help from a patient and national staff, Kathryn Sisterman, a U.S. nurse on her first assignment with Doctors Without Borders/Médecins Sans Frontières (MSF) in northern Central African Republic (CAR) developed a song to teach people about human African trypanosomiasis, also called sleeping sickness or trypano. Here, she describes how the song came to be.
Press Release | October 26, 2009
Geneva/Kampala, September 22, 2009 - NECT (Nifurtimox-Eflornithine Combination Therapy), the first new treatment in 25 years against Human African trypanosomiasis (HAT) or sleeping sickness, is now available. Endemic countries have now begun the process of ordering the new combination treatment and kits through the World Health Organization (WHO). Developed by DNDi and its partners, NECT cuts the cost of treatment by half and significantly reduces the burden on health workers. The announcement was made today at the International Scientific Council for Trypanosomiasi Research and Control (ISCTRC), in Kampala, Uganda.
Field News | October 26, 2009
Half a year after Doctors Without Borders/Médecins Sans Frontières (MSF) were forced to abandon its project in the northeastern Democratic Republic of Congo (DRC) due to the security situation, it is still not safe to return. Meanwhile, infection levels of sleeping sickness, which was a main focus of MSF’s activities in the area, are on the rise and many vulnerable people are at risk to the fatal disease.
Voice from the Field | October 26, 2009
"Since we left, at least 1,000 people have died of sleeping sickness in the region. It is unacceptable. We cannot stand here with our arms crossed and let people die that way. As soon as the situation allows, MSF will go back."
Special Report | October 26, 2009
A new treatment has potential to make a difference in the fight against sleeping sickness. The fatal parasitic disease, which has ravaged Africa for decades, is causing thousands of deaths each year and has been spreading from the Democratic Republic of Congo (DRC) with refugees and displaced, who are fleeing from conflict and do not have access to proper treatment.
Research Article | June 24, 2009
Voice from the Field | June 4, 2009
"Violence has never stopped, it has always been present. Sometimes it is the result of the political conflict between the government and armed groups and sometimes it is different: banditry or intra-community conflicts."
Press Release | May 15, 2009
Geneva/New York, May 15, 2009 – A new treatment option for sleeping sickness, a fatal disease that threatens 60 million people across sub-Saharan Africa, has been added to the Essential Medicines List (EML) of the World Health Organization (WHO). The inclusion of NECT (Nifurtimox-Eflornithine Combination Therapy) is based on an application submitted by the non-profit Drugs for Neglected Diseases initiative (DNDi), supported by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), and Epicentre, MSF’s epidemiological research center.
Press Release | February 23, 2009
Geneva/New York, February 23, 2009 — MSF and the Drugs for Neglected Diseases initiative (DNDi) called today for more sustainable funding for research and development (R&D) to tackle deadly, yet neglected diseases, such as sleeping sickness, visceral leishmaniasis, and Chagas disease, that affect millions of people around the world.
Speech | February 23, 2009
Press Release | December 9, 2008
New Orleans, Paris, Geneva; December 9, 2008 – Positive results from a pivotal, multi-center, multi-country Phase III trial investigating an improved treatment for the advanced stage of sleeping sickness were presented yesterday at the 57th Annual Meeting of the American Society of Tropical Medicine & Hygiene held in New Orleans, Louisiana, USA. This trial shows conclusively that NECT is a safe, effective, and practical treatment.
Research Article | October 22, 2008
Research Article | March 5, 2008
Research Article | February 8, 2008
Research Article | February 1, 2008
Research Article | November 7, 2007
Research Article | October 22, 2007
Press Release | November 15, 2006
Atlanta, November 15, 2006 — Preliminary results from a study conducted by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) show that significantly shorter and simplified treatment of African sleeping sickness (human African trypanosomiasis — HAT) could be possible in the near future. Announcing the study today at the 55th annual meeting of the American Society of Tropical Medicine and Hygiene in Atlanta, the organization stressed that measures must be undertaken to ensure that this treatment can be used as soon as possible at country level, and that older, toxic treatments are phased out."
Special Report | November 15, 2006
Preliminary results from a study conducted by Doctors Without Borders(MSF) show that significantly shorter and simplified treatment of African sleeping sickness could be possible in the near future.
Field News | May 1, 2006
Human African Trypanosomiasis, also known as African Sleeping Sickness, is a fatal and much neglected disease that continues to plague parts of Africa. The drug most commonly used to treat the disease is so toxic that it kills one in 20 patients. While a better drug exists, it is too complex to use in resource-poor settings. In the Democratic Republic of Congo (DRC), sleeping sickness has made a disturbing comeback over the past few decades.
Press Release | May 14, 2003
Press Release | March 14, 2002
Press Release | May 3, 2001
Special Report | August 1, 1997